Exhibit 10.27
COMPREHENSIVE TERMINATION AGREEMENT
This Comprehensive Termination Agreement (the "Agreement") is made as of this 24th day of October, 2022 (the "Effective Date") by and between Kissei Pharmaceutical Co., Ltd., a corporation duly organized and existing under the laws of Japan and having its registered office at 19-48, Yoshino, Matsumoto-City, Nagano-Prefecture 399-8710, Japan ("Kissei") and MediciNova, Inc., a corporation duly organized and existing under the laws of the State of Delaware, United States and having its registered office at 4350 La Jolla Village Dr., Ste. 950, San Diego, California 92122, USA ("MediciNova"). Each of Kissei and MediciNova is referred to herein as a "Party" and collectively, as the "Parties."
DOCPROPERTY"SWDocID" GDSVF&H\8723259.1
IN WITNESS WHEREOF, the Parties, each by their duly authorized officers, have executed this Agreement as of the Effective Date.
Kissei Pharmaceutical Co., Ltd. MediciNova, Inc.
By: | /s/ Mutsuo Kanzawa |
| By: | /s/ Yuichi Iwaki |
| Mutsuo Kanzawa |
|
| Yuichi Iwaki |
| Chief Executive Officer |
|
| President and CEO |
DOCPROPERTY"SWDocID" GDSVF&H\8723259.1